These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3311006)

  • 1. Lysophospholipids, long chain acylcarnitines and membrane dysfunction in the ischaemic heart.
    Corr PB; Saffitz JE; Sobel BE
    Basic Res Cardiol; 1987; 82 Suppl 1():199-208. PubMed ID: 3311006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amphipathic lipid metabolites and their relation to arrhythmogenesis in the ischemic heart.
    DaTorre SD; Creer MH; Pogwizd SM; Corr PB
    J Mol Cell Cardiol; 1991 Feb; 23 Suppl 1():11-22. PubMed ID: 2038071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arrhythmogenic properties of phospholipid metabolites associated with myocardial ischemia.
    Corr PB; Sobel BE
    Fed Proc; 1983 May; 42(8):2454-9. PubMed ID: 6840297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylaxis of early ventricular fibrillation by inhibition of acylcarnitine accumulation.
    Corr PB; Creer MH; Yamada KA; Saffitz JE; Sobel BE
    J Clin Invest; 1989 Mar; 83(3):927-36. PubMed ID: 2921326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subcellular distribution of endogenous long chain acylcarnitines during hypoxia in adult canine myocytes.
    McHowat J; Yamada KA; Saffitz JE; Corr PB
    Cardiovasc Res; 1993 Jul; 27(7):1237-43. PubMed ID: 8252583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selected metabolic alterations in the ischemic heart and their contributions to arrhythmogenesis.
    Corr PB; Yamada KA
    Herz; 1995 Jun; 20(3):156-68. PubMed ID: 7543431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha 1-adrenergic system and arrhythmias in ischaemic heart disease.
    Kurz T; Yamada KA; DaTorre SD; Corr PB
    Eur Heart J; 1991 Dec; 12 Suppl F():88-98. PubMed ID: 1666558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of gap junctional conductance by long-chain acylcarnitines and their preferential accumulation in junctional sarcolemma during hypoxia.
    Wu J; McHowat J; Saffitz JE; Yamada KA; Corr PB
    Circ Res; 1993 Apr; 72(4):879-89. PubMed ID: 8443874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent insights pertaining to sarcolemmal phospholipid alterations underlying arrhythmogenesis in the ischemic heart.
    McHowat J; Yamada KA; Wu J; Yan GX; Corr PB
    J Cardiovasc Electrophysiol; 1993 Jun; 4(3):288-310. PubMed ID: 8269301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delineation of the influence of propionylcarnitine on the accumulation of long-chain acylcarnitines and electrophysiologic derangements evoked by hypoxia in canine myocardium.
    Yamada KA; Dobmeyer DJ; Kanter EM; Priori SG; Corr PB
    Cardiovasc Drugs Ther; 1991 Feb; 5 Suppl 1():67-76. PubMed ID: 2031873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms contributing to the arrhythmogenic influences of alpha 1-adrenergic stimulation in the ischemic heart.
    Corr PB; Heathers GP; Yamada KA
    Am J Med; 1989 Aug; 87(2A):19S-25S. PubMed ID: 2548381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dependence of electrophysiological derangements on accumulation of endogenous long-chain acyl carnitine in hypoxic neonatal rat myocytes.
    Knabb MT; Saffitz JE; Corr PB; Sobel BE
    Circ Res; 1986 Feb; 58(2):230-40. PubMed ID: 3948341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection of the ischaemic myocardium by L-propionylcarnitine: effects on the recovery of cardiac output after ischaemia and reperfusion, carnitine transport, and fatty acid oxidation.
    Paulson DJ; Traxler J; Schmidt M; Noonan J; Shug AL
    Cardiovasc Res; 1986 Jul; 20(7):536-41. PubMed ID: 3779750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amphipathic metabolites and membrane dysfunction in ischemic myocardium.
    Corr PB; Gross RW; Sobel BE
    Circ Res; 1984 Aug; 55(2):135-54. PubMed ID: 6086176
    [No Abstract]   [Full Text] [Related]  

  • 15. Fatty acylcarnitine accumulation and membrane injury in ischemic canine myocardium.
    Chien KR; Sen A; Buja LM; Willerson JT
    Am J Cardiol; 1983 Oct; 52(7):893-7. PubMed ID: 6624683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accumulation of lysophosphoglycerides with arrhythmogenic properties in ischemic myocardium.
    Sobel BE; Corr PB; Robison AK; Goldstein RA; Witkowski FX; Klein MS
    J Clin Invest; 1978 Sep; 62(3):546-53. PubMed ID: 690185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the possible role of long chain fatty acylcarnitine accumulation in producing functional and calcium permeability changes in membranes during myocardial ischaemia.
    Lamers JM; De Jonge-Stinis JT; Verdouw PD; Hülsmann WC
    Cardiovasc Res; 1987 May; 21(5):313-22. PubMed ID: 3652098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of neurosympathetic responsiveness to early ventricular arrhythmias in ischaemic myocardium.
    Forfar JC; Riemersma RA; Russell DC; Oliver MF
    Cardiovasc Res; 1984 Jul; 18(7):427-37. PubMed ID: 6744363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A modified model of global ischaemia: application to the study of syncytial mechanisms of arrhythmogenesis.
    Ridley PD; Yacoub MH; Curtis MJ
    Cardiovasc Res; 1992 Apr; 26(4):309-15. PubMed ID: 1638559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-chain acylcarnitines determine ischaemia/reperfusion-induced damage in heart mitochondria.
    Liepinsh E; Makrecka-Kuka M; Volska K; Kuka J; Makarova E; Antone U; Sevostjanovs E; Vilskersts R; Strods A; Tars K; Dambrova M
    Biochem J; 2016 May; 473(9):1191-202. PubMed ID: 26936967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.